[ad_1]
World studies with corona preparations
Brief setback in AstraZeneca’s vaccine research.
Posted: September 12, 2020 5:39 pm
0
A few days after clinical trials of its corona vaccine were suspended, British-Swedish pharmaceutical company AstraZeneca resumed trials. The responsible supervisory authority has confirmed the safety, now human trials of the AZD1222 vaccine have started again in Britain, the company reports. It was suspended after a subject became ill.
On Wednesday, AstraZeneca announced that it had “voluntarily suspended” clinical trials after the subject fell ill. It was not disclosed what the patient became ill with. Then an independent panel of experts examined the case. Like AstraZeneca, the World Health Organization (WHO) also stated that such interruption in a series of tests is a routine measure. In its statement on Saturday, the pharmaceutical company said it is “committed to the safety of trial participants and the highest standards in clinical trials.”
Nine possible corona vaccines around the world
The AstraZeneca preparation is one of the nine potential vaccines in the world against the new coronavirus that are already in the final phase of testing III. The British-Swedish group developed the product together with the University of Oxford.
In addition to testing in the UK, AstraZeneca has also been investigating the effects of AZD1222 on 30,000 volunteers in a dozen US cities since late August. There are also smaller groups of test subjects in Brazil and other South American countries. The EU, US and other countries have already entered into agreements to supply the vaccine with the pharmaceutical company.
(Quelle: What / Afp)
Retrieved on September 13, 2020 at 01:04 am at https://www.salzburg24.at/news/welt/coronavirus-astrazeneca-nnahm-impfstofftests-wieder-auf-92733349
